Optimizing chemotherapy for older adults with advanced cancer

Standard chemotherapy regimens, which are mostly based on testing in relatively young and healthy patients, may do more harm to older adults with cancer who often struggle with other health issues.

From Comfort to Cure’: Answering the Call of ASCO 2024

Dr. Robert Den, Chief Medical Officer at Alpha Tau Medical The landscape of cancer treatment has continued to evolve, and the annual ASCO Meetings often

August 16, 2024

FDA approves Ipsen’s Onivyde as first-line treatment for type of pancreatic cancer

The FDA on Tuesday approved Ipsen’s cancer drug Onivyde as the first-line treatment for a type of pancreatic cancer, to be used alongside other cancer

February 14, 2024

Opioid Doc Sentenced; World’s First Sickle Cell Gene Tx; FTC Warns Diet Influencers

Note that some links may require registration or subscription. A Houston physician was sentenced to 10 years in prison for his role in a $5

November 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.